Literature DB >> 28959953

Biomarker strategy in lung cancer.

Mine Esencay1, Andrew Watson1, Kaushiki Mukherjee1, Delphine Hanicq1, Steven I Gubernick1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28959953     DOI： 10.1038/nrd.2017.166

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Precise medication for tumor patients in the context of mental stress.

Authors:  Qi-Shun Geng; Zhi-Bo Shen; Yuan-Yuan Zheng; Wen-Hua Xue; Li-Feng Li; Jie Zhao
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

2.  Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer.

Authors:  Chang Gon Kim; Gamin Kim; Kyung Hwan Kim; Seyeon Park; Sunhye Shin; Dahee Yeo; Hyo Sup Shim; Hong In Yoon; Seong Yong Park; Sang-Jun Ha; Hye Ryun Kim
Journal:  J Immunother Cancer       Date:  2021-12       Impact factor: 12.469
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.